We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
+20.59%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$195M
AUM Growth
–
Cap. Flow
+$180M
Cap. Flow %
92.65%
Top 10 Hldgs %
56.76%
Holding
117
New
116
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
STAA icon
STAAR Surgical
STAA
+$30.5M
2
ARWR icon
Arrowhead Research
ARWR
+$15.5M
3
ARCT icon
Arcturus Therapeutics
ARCT
+$15.4M
4
CLSD
Clearside Biomedical
CLSD
+$7.63M
5
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$6.48M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 79.63%
2 Technology 6.05%
3 Communication Services 5.12%
4 Financials 3.37%
5 Consumer Staples 1.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VTGN icon
76
VistaGen Therapeutics
VTGN
$12.2M
$315K 0.16%
+3,333
New +$247K
INFI
77
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$300K 0.15%
+100,200
New +$317K
SYRS
78
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$287K 0.15%
+5,250
New +$311K
YALA
79
Yalla Group
YALA
$815M
$270K 0.14%
+13,500
New +$273K
CTSO icon
80
Cytosorbents Corp
CTSO
$24.2M
$265K 0.14%
+35,000
New +$295K
CLRB icon
81
Cellectar Biosciences
CLRB
$20.1M
$259K 0.13%
+725
New +$314K
BNGO icon
82
Bionano Genomics
BNGO
$12.3M
$257K 0.13%
+58
New +$229K
KZIA
83
Kazia Therapeutics
KZIA
$137M
$247K 0.13%
+500
New +$263K
EGLX
84
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$238K 0.12%
+40,000
New +$272K
CYPH
85
Cypherpunk Technologies Inc
CYPH
$78M
$220K 0.11%
+13,400
New +$226K
TIL icon
86
Instil Bio
TIL
$49.2M
$194K 0.1%
+500
New +$185K
TCON
87
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$185K 0.1%
+1,425
New +$197K
CLGN icon
88
CollPlant Biotechnologies
CLGN
$5.86M
$160K 0.08%
+7,500
New +$120K
BTU icon
89
Peabody Energy
BTU
$2.78B
$159K 0.08%
+20,000
New +$118K
KC
90
Kingsoft Cloud Holdings
KC
$3.75B
$153K 0.08%
+4,500
New +$180K
GTH
91
DELISTED
Genetron Holdings Limited ADS
GTH
$152K 0.08%
+2,500
New +$154K
KPTI icon
92
Karyopharm Therapeutics
KPTI
$43.3M
$145K 0.07%
+933
New +$135K
ARAV
93
DELISTED
Aravive, Inc. Common Stock
ARAV
$141K 0.07%
+23,500
New +$124K
VTNR
94
DELISTED
Vertex Energy, Inc
VTNR
$139K 0.07%
+10,500
New +$43.5K
BLPH
95
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$121K 0.06%
+25,000
New +$112K
SDPI
96
DELISTED
Superior Drilling Products Inc.
SDPI
$113K 0.06%
+122,500
New +$103K
SQZ
97
DELISTED
SQZ Biotechnologies Company
SQZ
$109K 0.06%
+7,500
New +$98K
CHRS icon
98
Coherus Oncology
CHRS
$224M
$90K 0.05%
+6,500
New +$92.1K
AGTC
99
DELISTED
Applied Genetic Technologies Corporation
AGTC
$79K 0.04%
+20,000
New +$82.9K
BLRX
100
BioLineRX
BLRX
$11.8M
$78K 0.04%
+688
New +$80.9K
1 2 3
4
5

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2021 Portfolio in Review

Q2 2021 is the first quarter with a 13F filing on record for ACT Capital Management, which disclosed 117 positions worth $195M. Its ten largest holdings account for 57% of the portfolio.

Its largest position is STAAR Surgical: 231,600 shares worth $35.3M.

By sector, the portfolio is most concentrated in Healthcare at 80% of assets, followed by Technology and Communication Services.

  • ACT Capital Management's largest Q2 2021 buy was STAAR Surgical: 231,600 shares worth $35.3M.
  • ACT Capital Management's ten largest holdings make up 57% of its $195M portfolio in Q2 2021.
  • ACT Capital Management disclosed 117 positions in Q2 2021, its first 13F filing on record.

Based on ACT Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.